Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

NASDAQ:CRWD - Nasdaq - US22788C1053 - Common Stock - Currency: USD

467.92  +5.89 (+1.27%)

After market: 468.02 +0.1 (+0.02%)

Fundamental Rating

5

Taking everything into account, CRWD scores 5 out of 10 in our fundamental rating. CRWD was compared to 282 industry peers in the Software industry. The financial health of CRWD is average, but there are quite some concerns on its profitability. CRWD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
In the past year CRWD had a positive cash flow from operations.
In the past 5 years CRWD reported 4 times negative net income.
CRWD had a positive operating cash flow in each of the past 5 years.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

CRWD has a Return On Assets of -1.98%. This is comparable to the rest of the industry: CRWD outperforms 58.87% of its industry peers.
The Return On Equity of CRWD (-4.99%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a Gross Margin of 74.48%. This is in the better half of the industry: CRWD outperforms 64.89% of its industry peers.
In the last couple of years the Gross Margin of CRWD has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CRWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRWD has been increased compared to 1 year ago.
CRWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 13.70 indicates that CRWD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.70, CRWD belongs to the top of the industry, outperforming 90.43% of the companies in the same industry.
CRWD has a debt to FCF ratio of 0.73. This is a very positive value and a sign of high solvency as it would only need 0.73 years to pay back of all of its debts.
CRWD has a better Debt to FCF ratio (0.73) than 75.53% of its industry peers.
CRWD has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRWD (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Altman-Z 13.7
ROIC/WACCN/A
WACC11.08%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

CRWD has a Current Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Current ratio (1.85) which is in line with its industry peers.
CRWD has a Quick Ratio of 1.85. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CRWD (1.85) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

9

3. Growth

3.1 Past

CRWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.43%, which is quite good.
Measured over the past years, CRWD shows a very strong growth in Earnings Per Share. The EPS has been growing by 79.46% on average per year.
Looking at the last year, CRWD shows a very strong growth in Revenue. The Revenue has grown by 25.94%.
CRWD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 52.37% yearly.
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%

3.2 Future

The Earnings Per Share is expected to grow by 17.66% on average over the next years. This is quite good.
CRWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.08% yearly.
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 125.45, which means the current valuation is very expensive for CRWD.
Compared to the rest of the industry, the Price/Earnings ratio of CRWD is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 28.04, CRWD is valued quite expensively.
A Price/Forward Earnings ratio of 97.28 indicates a quite expensive valuation of CRWD.
CRWD's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.64. CRWD is valued rather expensively when compared to this.
Industry RankSector Rank
PE 125.45
Fwd PE 97.28
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRWD is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CRWD.
Industry RankSector Rank
P/FCF 113.7
EV/EBITDA 4561.49
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CRWD's earnings are expected to grow with 17.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.63%
EPS Next 3Y17.71%

0

5. Dividend

5.1 Amount

No dividends for CRWD!.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (7/25/2025, 8:00:00 PM)

After market: 468.02 +0.1 (+0.02%)

467.92

+5.89 (+1.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners73.11%
Inst Owner Change-0.28%
Ins Owners3.08%
Ins Owner Change2.67%
Market Cap116.63B
Analysts76.67
Price Target479.06 (2.38%)
Short Float %3.38%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.96%
Min EPS beat(2)9.3%
Max EPS beat(2)18.62%
EPS beat(4)4
Avg EPS beat(4)11.48%
Min EPS beat(4)5.05%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)12.45%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)21.52%
Revenue beat(2)1
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.53%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.32%
Revenue beat(16)8
Avg Revenue beat(16)0.45%
PT rev (1m)13.1%
PT rev (3m)16.77%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)2.84%
EPS NY rev (1m)0.02%
EPS NY rev (3m)2.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 125.45
Fwd PE 97.28
P/S 28.2
P/FCF 113.7
P/OCF 84.35
P/B 33.8
P/tB 48.35
EV/EBITDA 4561.49
EPS(TTM)3.73
EY0.8%
EPS(NY)4.81
Fwd EY1.03%
FCF(TTM)4.12
FCFY0.88%
OCF(TTM)5.55
OCFY1.19%
SpS16.59
BVpS13.85
TBVpS9.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.98%
ROE -4.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.48%
FCFM 24.8%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 0.73
Debt/EBITDA 30.51
Cap/Depr 155.6%
Cap/Sales 8.63%
Interest Coverage N/A
Cash Conversion 5666.88%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 13.7
F-Score4
WACC11.08%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-21.51%
EPS Next Y-8.77%
EPS Next 2Y10.63%
EPS Next 3Y17.71%
EPS Next 5Y17.66%
Revenue 1Y (TTM)25.94%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%19.8%
Revenue Next Year21.71%
Revenue Next 2Y21.78%
Revenue Next 3Y22.23%
Revenue Next 5Y22.08%
EBIT growth 1Y-861.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.18%
EBIT Next 3Y37.44%
EBIT Next 5Y36.81%
FCF growth 1Y37.6%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y34.63%
OCF growth 3Y33.96%
OCF growth 5Y69.1%